A conformation-specific ON-switch for controlling CAR T cells with an orally available drug.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: 2020-06-17

DOI: 10.1073/pnas.1911154117

Affiliations: 10

Authors: 14

Go to article
Institutions Share
St. Anna Children's Cancer Research Institute (CCRI), Austria 0.18
Max Perutz Labs Vienna, Austria 0.18
Institute of Immunology, MUW, Austria 0.14
Christian Doppler Laboratory for Next Generation CAR T Cells, Austria 0.13
Division of Biochemistry (DCH/BC), BOKU, Austria 0.11
Core Facility Biomolecular and Cellular Analysis (BmCA), BOKU, Austria 0.07
Harvard Department of Immunology, United States of America (USA) 0.07
Department of Pediatrics and Adolescent Medicine, MUW, Austria 0.04
St. Anna Children’s Hospital, Austria 0.04
Department of Chemistry and Biochemistry, University of Ljubljana, Slovenia 0.04

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER